Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YFY Biotech Management Company is the healthcare-focused venture capital and incubation arm of YFY Inc. (formerly Yuen Foong Yu), a major Taiwanese conglomerate. Established in 2003, the firm specializes in strategic investments and the incubation of high-potential enterprises within the biopharmaceutical, medical device, diagnostic, and healthcare technology sectors. It manages several funds, including the Taiwan Global Biofund (TGB), and provides integrated services such as technology evaluation, intellectual property management, and operational guidance to its portfolio companies. Notable successes include the founding and development of TaiGen Biotechnology and MiCareo. The company plays a pivotal role in bridging the gap between early-stage innovation and commercial success within the global life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YFY Bioscience.